Juliette Thariat

Author PubWeight™ 50.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol 2013 1.68
2 Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 2014 1.51
3 Myositis ossificans imaging: keys to successful diagnosis. Indian J Radiol Imaging 2012 1.36
4 Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 2012 1.30
5 Criteria to choose between distal or proximal venous port device insertion in HNC patients. Cardiovasc Intervent Radiol 2012 1.10
6 The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol 2011 1.09
7 Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. Int J Radiat Oncol Biol Phys 2011 1.07
8 Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer 2008 1.03
9 Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys 2008 1.00
10 Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg 2010 1.00
11 Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope 2008 0.99
12 Diplopia as the first symptom of an aggressive metastatic rectal stromal tumor. Onkologie 2009 0.96
13 Extraskeletal Osteosarcoma: An International Rare Cancer Network Study. Am J Clin Oncol 2016 0.93
14 Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors. Eur Arch Otorhinolaryngol 2009 0.92
15 Lethal, malignant, metastatic struma ovarii. Thyroid 2010 0.89
16 Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2012 0.89
17 Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 2008 0.86
18 Primary cancer of the sphenoid sinus--a GETTEC study. Head Neck 2009 0.86
19 Radical ablative surgery and radial forearm free flap (RFFF) reconstruction for patients with oral or oropharyngeal cancer: postoperative outcomes and oncologic and functional results. Acta Otolaryngol 2009 0.85
20 The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. Cancer Treat Rev 2012 0.84
21 Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg 2009 0.83
22 RE: Role of Duplex Doppler US for thyroid nodules: looking for the "sword" sign. Korean J Radiol 2011 0.82
23 [Imaging of the kidney]. Bull Cancer 2012 0.81
24 Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 2009 0.81
25 Synchronous parathyroid and papillary thyroid carcinomas. Thyroid 2009 0.81
26 Impact of dose-rate on the low-dose hyper-radiosensitivity and induced radioresistance (HRS/IRR) response. Int J Radiat Biol 2013 0.80
27 Main right renal artery originating from the superior mesenteric artery. Clin Anat 2011 0.80
28 Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study. Radiat Oncol 2014 0.80
29 Oral cavity squamous cell carcinoma in 260 patients aged 80years or more. Radiother Oncol 2009 0.79
30 Effects and consequences of Digisonic SP cochlear implant on radiotherapy planning. Eur Arch Otorhinolaryngol 2014 0.79
31 [Management of targeted therapies in hemodialysis patients]. Bull Cancer 2012 0.78
32 VEGF target in HHT lung patients: the role of bevacizumab as a possible alternative to embolization. Med Hypotheses 2012 0.78
33 Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid. Rare Tumors 2013 0.77
34 Insight into osteo-articular digital tomosynthesis: a pictorial essay. J Med Imaging Radiat Oncol 2012 0.77
35 [RCN, Rare Cancer Network]. Bull Cancer 2014 0.77
36 [Radiation-induced nephropathy]. Bull Cancer 2012 0.77
37 [The abscopal effect, synergy between immunotherapy and radiotherapy]. Bull Cancer 2013 0.76
38 [Management of chemotherapy in hemodialysis patients]. Bull Cancer 2012 0.76
39 [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view]. Bull Cancer 2012 0.76
40 Carcinosarcomas of the uterus should no longer be analyzed with uterine sarcomas. In reply to S. Sampath et al. (Int J Radiat Oncol Biol Phys, 2010;76:728-734). Int J Radiat Oncol Biol Phys 2010 0.76
41 [American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view]. Bull Cancer 2011 0.76
42 Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor status. Onkologie 2013 0.76
43 Reirradiation in head and neck cancers. Anticancer Drugs 2011 0.75
44 Intra- and interobserver variability of US elastography: how does it affect quality? Radiology 2011 0.75
45 Re: Tips and tricks of percutaneous gastrostomy under image guidance in patients with limited access. Korean J Radiol 2011 0.75
46 Letter: "Prognostic value of initial tumor parameters after metastatic relapse: do not miss the tumoral stroma". Cancer Invest 2012 0.75
47 Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy? Medicine (Baltimore) 2016 0.75
48 Lung air cysts: think patient history and immunity status. AJR Am J Roentgenol 2012 0.75
49 [State of the art in nuclear imaging for the diagnosis of bone metastases]. Bull Cancer 2013 0.75
50 Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases. Graefes Arch Clin Exp Ophthalmol 2014 0.75
51 Features of cancer management in obese patients. Crit Rev Oncol Hematol 2012 0.75
52 Neck dissection and chemoradiation in head and neck cancer. Lancet Oncol 2010 0.75
53 Response to "The correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy (IMRT) for head-and-neck cancer." (Int J Radiat Oncol Biol Phys 2011;81:e207-e213.). Int J Radiat Oncol Biol Phys 2012 0.75
54 Letter to the Editor re: "Outcome analysis in 3160 implantations of radiologically guided placements of totally implantable central venous port systems": observations about right internal jugular access. Eur Radiol 2011 0.75
55 Gradient-PET based delineation may be improved with combined post contrast high resolution CT scan: in regard to Werner-Wasik M et al. (Int J Radiat Oncol Biol Phys 2011 Apr 28). Int J Radiat Oncol Biol Phys 2012 0.75
56 Further data about hypoxic pulmonary hypertension. AJR Am J Roentgenol 2012 0.75
57 Therapeutic options for patients with a single lung with a pulmonary tumor. Radiology 2011 0.75
58 Imaging work up of small aggressive lymph nodes: in regard to Ghadjar et al. (Int J Radiat Oncol Biol Phys 2010;78:1366-1372). Int J Radiat Oncol Biol Phys 2011 0.75
59 Percutaneous removal of embolized port catheter: The standard option. Catheter Cardiovasc Interv 2008 0.75
60 Low or high fractionation dose B-radiotherapy for pterygium? A randomized clinical trial: in regard to Viani GA et al. (Int J Radiat Oncol Biol Phys 2010;10.1016/j.ijrobp.2010.11.017). Int J Radiat Oncol Biol Phys 2012 0.75
61 Human papillomavirus-positive basaloid squamous cell carcinomas of the head and neck. Hum Pathol 2010 0.75
62 Value of combined PET/contrast-enhanced high-resolution CT fusion imaging for lung cancer. AJR Am J Roentgenol 2012 0.75
63 Benefit of optimizing the dose to the carotid in hypofractionated stereotactic body reirradiation? Int J Radiat Oncol Biol Phys 2011 0.75
64 Should we catch the train of shear-wave elastography? AJR Am J Roentgenol 2012 0.75
65 Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis. J Clin Oncol 2008 0.75
66 [Risk of cancer in patients following chronic dialysis and kidney graft]. Bull Cancer 2012 0.75
67 Zenker's diverticulum: the diagnostic power of ultrasound. Thyroid 2010 0.75
68 [Treatment of primary thyroid lymphomas]. Bull Cancer 2013 0.75
69 Pneumatization of the skull base due to valsalva maneuver. Cleft Palate Craniofac J 2012 0.75
70 Cerebellar relapse of Hodgkin lymphoma. Leuk Lymphoma 2009 0.75
71 [Imaging of bone metastases]. Bull Cancer 2013 0.75
72 [Otorhinolaryngology thematic issue. Presentation]. Bull Cancer 2014 0.75
73 [Kidney and cancer: cross-over management]. Bull Cancer 2012 0.75
74 Blind aortic cannulation. J Vasc Access 2012 0.75
75 Superior vena cava syndrome: do not miss the Ariadne's thread. Diagn Interv Radiol 2012 0.75
76 [Radiotherapy of bone metastases]. Bull Cancer 2013 0.75
77 Dealing with vanishing central veins. J Vasc Access 2013 0.75
78 [p16 protein in other than gynecologic lesions]. Ann Pathol 2010 0.75
79 [Specificity of bone metastases: pan-oncologic issues]. Bull Cancer 2013 0.75
80 Primitive neuroectodermal tumor of the pelvis in an elderly patient. Onkologie 2009 0.75
81 Interaction between non-anionic phospholipids and cytochrome c induced by reactive oxygen species. Chem Phys Lipids 2010 0.75
82 Oncology scan--nodal regions, nodal regression, and molecular biomarkers: new thinking in head and neck radiation therapy. Int J Radiat Oncol Biol Phys 2014 0.75
83 Improving Head and Neck Cancer Outcomes: Technology, Used Wisely. Int J Radiat Oncol Biol Phys 2016 0.75
84 [Involvement of the cytomegalovirus in mucoepidermoid carcinomas of the salivary glands?]. Bull Cancer 2015 0.75